Drug profile · INN
orphenadrine hydrochloride
DISIPAL
orphenadrine hydrochloride (DISIPAL) is a norepinephrine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — orphenadrine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
orphenadrine hydrochloride (DISIPAL) is a norepinephrine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Norepinephrine transporter inhibitor
Primary target: Glutamate [NMDA] receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is orphenadrine hydrochloride?
orphenadrine hydrochloride (DISIPAL) is a norepinephrine transporter inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for orphenadrine hydrochloride?
DISIPAL is a marketed brand name for orphenadrine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of orphenadrine hydrochloride?
orphenadrine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.